Compounds > ethinyl estradiol
Page last updated: 2024-08-17

ethinyl estradiol and ezetimibe

ethinyl estradiol has been researched along with ezetimibe in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TK; Ensom, MH; Kiang, TK1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Compton, DS; Davis, HR; Farley, C; Hoos, L; van Heek, M1

Reviews

1 review(s) available for ethinyl estradiol and ezetimibe

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005

Other Studies

3 other study(ies) available for ethinyl estradiol and ezetimibe

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Animals; Anticholesteremic Agents; Azetidines; Biliary Tract Surgical Procedures; Carbon Radioisotopes; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cricetinae; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ezetimibe; Intestinal Absorption; Intestinal Mucosa; Liver; Male; Mesocricetus; Pancreas; Progesterone; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Triolein; Tritium; Vitamin A; Vitamin D

2001